Analysts have been eager to weigh in on the Materials sector with new ratings on Golden Minerals Co (AUMN – Research Report), Evolution Mining Limited (CAHPF – Research Report) and IGO (IPGDF – Research Report).
Golden Minerals Co (AUMN)
In a report released yesterday, Siddharth Rajeev from Fundamental Research reiterated a Buy rating on Golden Minerals Co, with a price target of $0.79. The company’s shares closed last Tuesday at $0.26, close to its 52-week low of $0.22.
According to TipRanks.com, Rajeev is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Golden Minerals Co with a $0.70 average price target.
See today’s best-performing stocks on TipRanks >>
Evolution Mining Limited (CAHPF)
J.P. Morgan analyst Al Harvey downgraded Evolution Mining Limited to Hold yesterday and set a price target of A$2.90. The company’s shares closed last Tuesday at $1.60, close to its 52-week low of $1.55.
According to TipRanks.com, Harvey is a 2-star analyst with an average return of
Evolution Mining Limited has an analyst consensus of Hold, with a price target consensus of $2.03, a 31.0% upside from current levels. In a report issued on August 18, UBS also maintained a Hold rating on the stock with a A$2.80 price target.
IGO (IPGDF)
J.P. Morgan analyst Lyndon Fagan maintained a Buy rating on IGO yesterday and set a price target of A$14.00. The company’s shares closed last Tuesday at $9.07.
According to TipRanks.com, Fagan is a 4-star analyst with an average return of
IGO has an analyst consensus of Moderate Buy, with a price target consensus of $9.24, implying a 3.4% upside from current levels. In a report issued on August 22, Macquarie also maintained a Buy rating on the stock with a A$21.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AUMN:
- Ascendis Pharma Submits TransCon™ PTH New Drug Application to the U.S. FDA for Adult Patients with Hypoparathyroidism
- J.P. Morgan downgrades Hydrofarm Holdings Group (HYFM) to a Hold
- J.P. Morgan downgrades Invitae (NVTA) to a Sell
- Singular Genomics Systems (OMIC) was downgraded to a Hold Rating at J.P. Morgan
- Berkeley Lights (BLI) was downgraded to a Hold Rating at J.P. Morgan